002932 明德生物
按盤價 
16.610 -1.850 (-10.022%)
16.610 -1.850 (-10.022%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 0.237 | 1.257 | 1.196 | 90.614 | 72.648 |
| 總資產報酬率 ROA (%) | 0.213 | 1.066 | 0.904 | 66.739 | 58.353 |
| 投入資產回報率 ROIC (%) | 0.233 | 1.232 | 1.134 | 84.568 | 67.585 | 邊際利潤分析 |
| 銷售毛利率 (%) | 32.311 | 53.891 | 54.278 | 66.846 | 75.015 |
| 營業利潤率 (%) | -7.560 | 11.766 | 19.371 | 48.240 | 59.997 |
| 息稅前利潤/營業總收入 (%) | -3.053 | 6.530 | 19.356 | 47.876 | 59.674 |
| 淨利潤/營業總收入 (%) | -5.488 | 7.589 | 9.235 | 41.600 | 51.123 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 2,017.257 | -254.385 | 21.010 | 118.847 | 100.883 |
| 價值變動淨收益/利潤總額(%) | -1,395.567 | 417.818 | 89.456 | 0.746 | 0.040 |
| 營業外收支淨額/利潤總額(%) | -224.871 | -27.057 | -3.792 | -0.068 | -0.192 | 償債能力分析 |
| 流動比率 (X) | 15.954 | 4.835 | 2.698 | 3.248 | 5.495 |
| 速動比率 (X) | 15.614 | 4.669 | 2.571 | 3.139 | 4.974 |
| 資產負債率 (%) | 6.125 | 8.712 | 14.817 | 26.349 | 16.594 |
| 帶息債務/全部投入資本 (%) | 0.384 | 0.411 | 1.131 | 6.906 | 3.398 |
| 股東權益/帶息債務 (%) | 25,616.124 | 23,884.636 | 8,631.677 | 1,336.184 | 2,821.838 |
| 股東權益/負債合計 (%) | 1,488.110 | 1,014.342 | 550.562 | 268.294 | 491.842 |
| 利息保障倍數 (X) | 4.207 | -2.392 | 27.931 | -144.295 | -287.170 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 843.393 | 1,014.913 | 905.102 | 56.380 | 58.484 |
| 存貨周轉天數 (天) | 161.494 | 235.376 | 203.374 | 27.998 | 102.427 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 23/03/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
